AT A GLANCE

MUST READS FROM THE HEALTHCARE SECTOR

 
Deloitte Final Report Feb 2010

This report explores the contribution of the pharmaceutical industry to the South African economy



IMSA Corporate Profile 2011

IMSA's Yearly Corporate Profile



Managed Care Study

This study analysed the perceptions of health professionals of managed care in SA.



NMG Report

This report investigated how employers choose medical scheme cover for employees and the awareness/ perceptions of value of offerings.



 

Innovative Medicines South Africa (IMSA) is a pharmaceutical industry association which represents research-based pharmaceutical companies that originate, develop and market medicines.

As an innovation-based industry body, IMSA endorses the value of recognising the symbiotic relationship between patented and off-patented medicines to advance healthcare for all in South Africa.

girl

Our founding principles are based on the following facts:

  • the source of all generic medicines is patented medicines;
  • savings on medicines by consumers are generated by generic manufacturing competitors, which promotes further access to innovative medicines;
  • generic medicines contribute substantially to improving patient health in general;
  • however, to satisfy as yet unmet medical needs, it remains essential to originate new and better medicines.
 

IMSA MEMBERS FORUM

IMSA MEMBERS FORUM

 
log in

Subscribe to NHI Library Updates

SUBSCRIBE TO NHI LIBRARY UPDATES

click here

PHARMACEUTICAL INDUSTRY RESOURCES

PHARMACEUTICAL INDUSTRY RESOURCES

 
click here

POLICY BRIEFS

NATIONAL HEALTH INSURANCE POLICY BRIEFS

click here

MEDICAL SCHEME INFORMATION TOOL

MEDICAL SCHEME INFORMATION TOOL

 
click here

First Things First

first things

An innovative, voluntary HIV testing, counselling and education campaign aimed at tertiary students and staff.

To learn more:

click here

IMSA COMPANIES

  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo
  • logo